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Epidermolysis bullosa simplex is a group of blistering skin disorders caused by
defects in one of the keratin genes, KRT5 and KRT14. Previously reported KRT5
and KRT14 mutations are clustered in several hotspots, namely the rod ends of the
1A and 2B domains and in the non-helical linker region L12. Therefore, genomic
KRT5 and KRT14 mutation analysis was initially limited to these hotspots. In this
study we describe the screening of nine EBS patients for mutations in the hotspots.
In two patients, with the Koebner and the Weber-Cockayne subtypes of
epidermolysis bullosa simplex respectively, we could, however, not identify any
mutation in one of the hotspot domains of KRT5 and KRT14. Therefore, it appeared
to be necessary to screen the entire genes for mutations. For KRT5, a complete
genomic mutation detection system was previously described. We now developed a
complete genomic mutation detection system for KRT14. For the amplification of the
KRT14 genes, we make use of restriction sites to exempt the keratin 14 pseudogene
sequence from polymerase chain reaction amplification. Using the complete
genomic mutation detection system for both KRT5 and KRT14, we identified four
novel KRT5 mutations (IVS1-1G>C, K404E, A438D, E475K), two of which are
outside the KRT5 hotspot domains, and three novel KRT14 mutations (IVS4+1G>A,
L408M, L130P).
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Introduction
Epidermolysis bullosa simplex (EBS) is an inherited skin disease characterised by
intraepidermal blistering upon mild mechanical trauma. The blistering is caused by a
mutation in either of the keratin genes, KRT5 (MIM# 148040) or KRT14 (MIM#
148066). These genes code for keratin 5 (K5) and keratin 14 (K14) polypeptides,
respectively. Together these polypeptides form heterodimers that assemble into the
keratin filament network of the basal cells in the epidermis (Steinert, 1990; Hatzfeld
& Weber, 1990; Fuchs, 1996). Disturbances of the keratin filament network, caused
by alterations in one of the keratin molecules, will lead to skin fragility and blistering.
Previously reported mutations identified in KRT5 and KRT14 include for the greater
part nucleotide substitutions. The majority lead to missense mutations, however also
a few splice site mutations and nonsense mutations are identified. In EBS due to
keratin mutations, most mutations have an autosomal dominant mode of inheritance,
although autosomal recessive mutations have been described in rare cases
(Hovnanian et al., 1993; Rugg et al., 1994; Chan et al., 1994; Jonkman et al., 1996;
Hut et al., 2000). A summary of all reported KRT5 mutations is given in Table I. A list
of reported KRT14 mutations has recently been published (Hut et al., 2000).
For KRT5, a genomic mutation detection system has already been described
(Stephens et al., 1997), as for the KRT14 hotspot domains (Hut et al., 2000).
Although most of the EBS mutations could be identified in the mutation hotspots of
KRT5 and KRT14, occasionally a mutation is located outside the hotspots (Jonkman
et al., 1996; Humphries et al., 1996; Liovic et al., 2001). Upon screening of nine
patients, we found two patients, one with EBS-Koebner and the other one with EBS-
Weber-Cockayne, both with no detectable mutation in the hotspot domains of KRT5
and KRT14, suggesting a mutation outside the hotspot domains. We therefore
completed the genomic mutation detection system encompassing the complete
coding region of the KRT5 and KRT14 gene. In addition, we identified four novel




Table I Summary of reported keratin 5 mutations identified in patients with epidermolysis
bullosa simplex
∗the numbering indicates the codon numbers
 169–203   216–316  334–352         361-481
    L1                L1-2         L2
1B1A
            1-168 *            204-215        317-333  353-360           482-590
head tail
2B2A
KRT5 exon 1    2    3       4 5    6         7         8 9
Exon Codon Triplet Amino acid Phenotype Reference
1 1
24 CCG-CTG Pro-Leu EBS, Mottled Pigmentation Irvine et al., 1997b; Moog et al., 1999
156 CCC-CTC Pro-Leu EBS, Weber-Cockayne Müller et al., 1998
161 ATC-AGC Ile-Ser EBS, Weber-Cockayne Ehrlich et al., 1995
173 AAG-AAC Lys-Asn EBS, Koebner Stephens et al., 1995
174 CTC-TTC Leu-Phe EBS, Dowling-Meara Nomura et al., 1996
176 AAC-AGC Asn-Ser EBS, Dowling-Meara Stephens et al., 1997; Sørensen et al., 1999
179 TTT-TCT Phe-Ser EBS, Dowling-Meara Stephens et al., 1997
181 TCC-CCC Ser-Pro EBS, Dowling-Meara Shemanko et al., 2000
IVS1+1G>A ∆Val164-Lys185 EBS, Dowling-Meara Rugg et al., 1999
IVS1-1G>C ∆Val186-Gln191 EBS, Koebner this study
2 186
186 GTG-TTG Val-Leu EBS, Koebner Liovic et al., 2001; Liovic et al., 2001




323 GTG-GCG Val-Ala EBS, Koebner Galligan et al., 1998
325 CTC-CCC Leu-Pro EBS, Koebner Sørensen et al., 1999
327 ATG-AAG Met-Lys EBS, Weber-Cockayne Müller et al., 1998
327 ATG-ACG Met-Thr EBS, Weber-Cockayne Chan et al., 1994; Humphries et al., 1996
328 GAC-GAA Asp-Glu EBS, Weber-Cockayne Liovic et al., 2000
328 GAC-CAC Asp-His EBS, Weber-Cockayne Müller et al., 1998
328 GAC-GTC Asp-Val EBS, Weber-Cockayne Matsuki et al., 1995
329 AAC-AAA Asn-Lys EBS, Weber-Cockayne Chan et al., 1994
331 CGC-TGC Arg-Cys EBS, Weber-Cockayne Rugg et al., 1993
6 365
404 AAG-GAG Lys-Glu EBS, Weber-Cockayne this study
7 407
438 GCC-GAC Ala-Asp EBS, Weber-Cockayne this study
463 CTG-CCG Leu-Pro EBS, Koebner Dong et al., 1993
466 ATC-ACC Ile-Thr EBS, Dowling-Meara Irvine et al., 1997a
472 AAG-TAG Lys-Term EBS, Palmar-Plantar Hyperkeratosis Livingston et al., 2001
475 GAG-GGG Glu-Gly EBS, Dowling-Meara Lane et al., 1992
475 GAG-AAG Glu-Lys EBS, Dowling-Meara this study
477 GAG-AAG Glu-Lys EBS, Dowling-Meara Stephens et al., 1997, this study








The clinical phenotypes of the nine patients included in this study are summarised in
Table II. The expression of K5 in the skin of patient I as detected by
immunofluorescence microscopy using monoclonal antibodies RCK102 (kind gift of
dr. F.C.S. Ramaekers, Maastricht) and AE14 (gift of dr. T.-T. Sun, New York) was
unreduced. Electron microscopy of a blister revealed a split level in the subnuclear
zone of basal keratinocytes consistent with the diagnosis EBS. Ultrastructural
examination of affected skin showed thick bundles of intermediate filaments (lateral
aggregation) in basal cells, but no signs of keratin clumping.
Table II Clinical phenotypes and mutations found in EBS patients included in this study
* Conservation of the particular residue in all IF chains according to Conway & Parry, 1988.
Patient Clinical phenotype KRT5 mutation KRT14 mutation Inheritance Conservation* Side chain
I EBS-K IVS1-1G>C unknown
II EBS-K IVS4+1G>A familial
III EBS-WC K404E unknown yes basic > acidic
IV EBS-WC L408M unknown yes nonpolar > nonpolar
V EBS-WC A438D de novo yes nonpolar > acidic
VI EBS-DM L130P unknown yes nonpolar > nonpolar
VII EBS-DM L419Q familial yes nonpolar > uncharged polar
VIII EBS-DM E475K familial yes acidic > basic
IX EBS-DM E477K de novo yes acidic > basic
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Genomic mutation detection analysis
DNA was isolated from peripheral blood using the high salt/ chloroform extraction
method (Miller et al., 1988). The primer sequences and the PCR programs used for
amplification of the particular amplicons of KRT5 and KRT14 are given in Table III.
Mutation analysis of KRT5 and the hotspots of KRT14 was generally carried out
using a method previously described (Stephens et al., 1997; Hut et al., 2000). Only
for KRT5 exons 2, 6 and 9 new primers were designed, because of the large
distances between the position of the primers to the intron/exon boundary. For all
amplicons of the genomic KRT14 mutation detection system located inside as well
as outside the mutation hotspot domains, we made use of a digestion step of the
genomic DNA prior to amplification, because of the presence of a highly homologous
keratin 14 pseudogene (Savtchenko et al., 1988). These restriction enzymes cleave
the keratin 14 pseudogene sequences while leaving the functional KRT14
sequences intact. Next, the sequences of the functional KRT14 gene were amplified
and subjected to direct sequencing using the Big Dye Terminator Kit and an
automated ABI 377 DNA sequencer (Perkin Elmer, Norwalk, CT).
RNA analysis
In the DNA of patient I we identified a novel KRT5 splice site mutation, IVS1-1G>C.
To investigate the effect of this mutation at the RNA level, we performed RNA
analysis. Keratinocytes of patient I were harvested from a skin biopsy and cultured
under serum-free conditions. RNA was extracted from the keratinocyte culture by
using Trizol reagent (GibcoBRL, Rockville, USA). The Ready-To-Go You-Prime
First-Strand Beads (Amersham Pharmacia Biotech AB, Uppsala, Sweden) and
random primers were used for the synthesis of first-strand cDNA. After cDNA
synthesis, a RT-PCR was carried out with the forward primer B1 and the reverse
primer C2 (Stephens et al., 1997) with annealing at 60oC. After amplification, the RT-
PCR products were purified using the high pure PCR product purification kit
(Boehringer Mannheim, Basel, Switzerland). Subsequently, the products were
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subjected to direct sequencing using the Big Dye Terminator Kit and an automated
ABI 377 DNA sequencer (Perkin Elmer, Norwalk, CT).
Table III Primers and PCR programs for genomic keratin 5 and keratin 14 mutation detection
Gene Exon Enzyme Forward primer Reverse primer PCR program Reference
KRT5 1 gagctctgttctctccagca ccttctttctctctctttggc I Stephens et al., 1997
gctatggctttggaggtggt ccttctttctctctctttggc I Stephens et al., 1997
2 gatcatagaacttgaaatcc ccatctggtaccaagaagac I Stephens et al., 1997, this study,
3 tggccagaggttcatgctac tcaaccttggcctccagctcc II Stephens et al., 1997
4 gagaaccagcagcctgcag tgaggtgtcagagacatgc I Stephens et al., 1997
5 atgagattaacttcatgaagatg ccattcttagtgtcgtcatg I Stephens et al., 1997
gtatgaggagattgccaacc tttagaactcaggccccttc I Stephens et al., 1997
6 ctcactgcctgtgaactttg tttagaactcaggccccttc I Stephens et al., 1997, this study
7 gagagccgagattgacaatg tagagcagcctcgctttatc I Stephens et al., 1997
8 tcgaatcatgaggatgggag gaggaaacactgcttgtga II Stephens et al., 1997
9 taaatgggccatgcaggatc agaagaggcaatctccatgg I this study
KRT14 1 TaqI cagctccatgaagggctcc gagctagctggaatggtgcc III Hut et al., 2000
2 AluI gacaaattacctgtgccttt gcccaagagtcttattcttt IV Hut et al., 2000
3 SphI gcactgtgttcaaccacgcc tcctgtctcagcctcccaag V this study
4 SphI caggcctaaggaacaccaat gagaatgccattcacaccag VI Hut et al., 2000
5 NspI gtgtcatttgaggtggaagg attagtgagtgtggccgttc V this study
6 MseI gaacggccacactcactaat cattagatacatggtggggc VI Hut et al., 2000
7 MseI ggagtacaagatcctgctgg ctagccaatgcctagacctg V this study
8 Sau3AI tcctcaccttcttggcctcc gctgggcagcctcagttctt V this study
PCR program I: 94oC 1’ 55oC 1’ 72oC 1’ 35x
II: 94oC 1’ 61oC 1’ 72oC 1’ 35x
III: 95oC 3’ 60oC 1’ 72oC 1’ 1x
94oC 1.5’ 60oC 1’ 72oC 1’ 3x
94oC 1.5’ 58oC 1’ 72oC 1’ 4x
94oC 1.5’ 56oC 1’ 72oC 1’ 4x
94oC 1.5’ 55oC 1’ 72oC 1’ 18x
IV: 94oC 4’ 1x
94oC 1’ 52oC 1’ 72oC 1’ 30x
72oC 6’ 20oC 10’ 1x
V: 94oC 1’ 60oC 1’ 72oC 1’ 30x




In KRT5 of patient I (EBS-K), at the junction of intron 1 and exon 2, a heterozygous
G to C transversion was identified (IVS1-1G>C). Through the presence of this
mutation, the splice acceptor site of KRT5 exon 2 had been modified. No other
mutation within the coding sequences or within the flanking intronic sequences of
KRT5 and KRT14 had been identified. The parents were unaffected. The mutation
was absent in the father. The mother was unavailable for molecular examination. At
the RNA level, this novel splice site mutation, IVS1-1G>C, resulted in in-frame
skipping of the first 18 bp of exon 2, leading to an aberrant K5 protein with a deletion
of 6 amino acids.
In KRT14 of patient II (EBS-K), a heterozygous G to A transition was identified at
position 3141, situated at the junction of exon 4 and intron 4. Due to this transition,
the splice donor site of KRT14 exon 4 is being modified. This novel splice site
mutation, IVS4+1G>A, was also identified in the affected mother of the patient.
In KRT5 exon 6 of patient III (EBS-WC), a heterozygous A to G transition was
identified. Due to this transition, codon 404 for lysine (AAG) was changed into a
codon for glutamic acid (GAG). This novel mutation is designated K404E.
In KRT14 of patient IV (EBS-WC), a heterozygous C to A transition was
identified. Due to this transition, codon 408 for leucine (CTG) was changed into a
codon for methionine (ATG). The presence of this novel mutation, L408M, was
excluded in the DNA of the asymptomatic mother.
In patient V (EBS-WC), a heterozygous C to A transition in KRT5 exon 7 was
identified. The transition changes codon 438 for alanine (GCC) into a codon for
aspartic acid (GAC). This novel mutation is designated A438D. The presence of this
mutation was excluded in the DNA of the parents.
In KRT14 of patient VI (EBS-DM), a heterozygous T to C transition was
identified. Due to this transition, codon 130 for leucine (CTG) was changed into a
codon for proline (CCG). This novel mutation is designated L130P.
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In KRT14 of patient VII (EBS-DM), a heterozygous T to A transversion was
identified. This transversion changes codon 419 for leucine into a codon for
glutamine. The presence of this mutation, L419Q, which was also identified in the
affected mother of the patient, has been described previously (Hut et al., 2000).
In patient VIII (EBS-DM), a heterozygous G to A transition in KRT5 exon 7 was
identified. The transition changes codon 475 for glutamic acid (GAG) into a codon for
lysine (AAG). This novel mutation, E475K, was also present in the affected father of
the patient and was absent in the asymptomatic mother.
In KRT5 exon 7 of patient IX (EBS-DM), a heterozygous G to A transition was
identified. The transition changes codon 477 for glutamic acid (GAG) into a codon for
lysine (AAG). The mutation is not present in both unaffected parents. This mutation,
E477K, was described previously (Hut et al., 2000).
Conclusion and discussion
Using a complete mutation detection system, three novel dominant KRT14 mutations
were identified in this study, of which two missense mutations (L130P and L408M)
and one splice site mutation (IVS4+1G>A). The missense mutation L130P (EBS-
DM) results in an amino acid alteration in domain 1A of the K14 protein. The
missense mutation L408M (EBS-WC) results in an amino acid alteration in domain
2B of the K14 protein. The presence of the KRT14 splice site mutation, IVS4+1G>A
(EBS-K), modifies the splice donor site of KRT14 exon 4. The dominant KRT14
missense mutation L419Q (EBS-DM), resulting in the alteration of a nonpolar amino
acid into an uncharged polar amino acid in domain 2B, was described previously in
association with EBS-DM (Hut et al., 2000). All described mutations that cause the
most severe subtype of EBS, EBS-DM, occur either at the start of the 1A rod domain
or at the end of rod domain 2B in both KRT5 and in KRT14. This is consistent with
the theory that these rod ends play an important role in keratin filament network
formation (Steinert et al., 1993). All three missense mutations result in an amino acid
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alteration of a conserved residue of the keratin gene family (Conway & Parry, 1988),
suggesting that these mutations are pathogenic.
In this study, we furthermore identified four novel KRT5 mutations of which three
missense mutations and one splice site mutation. The three novel dominant
missense mutations, K404E (EBS-WC), A438D (EBS-WC) and E475K (EBS-DM),
respectively, all result in an amino acid alteration in domain 2B of the K5 protein
(Table II). K404E results in the alteration of an amino acid with a basic side chain
into an amino acid with an acidic side chain. The mutation A438D changes a
nonpolar amino acid into an acid amino acid, and the mutation E475K results in the
change of an acid amino acid into a basic amino acid. An alteration of codon 475 of
the KRT5 gene has been described previously in association with EBS-DM (Lane et
al., 1992). The dominant mutation E477K (EBS-DM), also resulting in an alteration in
domain 2B of the K5 protein, has been described previously in association with EBS-
DM (Stephens et al., 1997; Hut et al., 2000). This mutation results in the change of
an amino acid with an acidic side chain into an amino acid with a basic side chain.
All the identified KRT5 missense mutations alter a conserved residue of the keratin
gene family (Conway & Parry, 1988), and change the charge and/or the polarity of
the particular residue, suggesting that these mutations affect the protein winding and
protein-protein interactions and may therefore be pathogenic.
The identified KRT5 splice site mutation, IVS1-1G>C, in the EBS-K patient will
result in an alteration in the 1A rod domain of K5. Since the reading frame is still
intact, an aberrant K5 molecule missing amino acids 186-191 will be formed. As
mentioned, both dominant and recessive forms of EBS exist. For this splice site
mutation, it is hard to predict whether it acts in a dominant or a recessive manner.
The dominant mode of inheritance of most of the EBS mutations could be explained
by the fact that the keratin filament network is built up of heterodimers composed of
both a K5 and a K14 molecule. An alteration in one of these keratin molecules, either
caused by a missense mutation or an in-frame splice site mutation, may interfere
with correct heterodimer formation, leading to disturbance of the keratin filament
network, resulting in skin fragility and skin blistering. Mutations that lead to a
premature termination codon probably result in non-participation of the specific
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protein in keratin filament network formation, and will show a recessive mode of
inheritance. Hence, in case of a heterozygous recessive mutation, there will be
enough of the specific protein for participation in dimer formation. In case of a
homozygous recessive mutation, the specific keratin molecule will be missing
resulting in no or abnormal homodimer formation. Most likely, truncated K5
polypeptide gains a dominant-negative effect. This idea is strengthened by the fact
that no second mutation is found, although it can not be excluded that a mutation is
missed by this system approach.
Using this EBS mutation detection system, eighteen EBS patients have been
screened for KRT5 and KRT14 mutations in our lab. Nine of the eighteen EBS
patients are described in this study, the other nine EBS patients have been
described previously (Jonkman et al., 1996; Moog et al., 1999; Hut et al., 2000). In
all eighteen patients screened we found a mutation in either gene, i.e. nine different
mutations in KRT14 including one outside the hotspots, and six different mutations in
KRT5 including two outside the hotspots. Thus, with the design of the primers for
genomic KRT14 mutation analysis outside the hotspots, we have completed the
development of a robust genomic mutation detection system for epidermolysis
bullosa simplex.
For EBS mutation screening, we recommend to start with mutation analysis of
the hotspots of KRT5 and KRT14, as most EBS mutations are identified in these
regions. If no mutation is identified, it is worthwhile to screen the entire KRT5 gene, if
necessary followed by a mutation screening of the entire KRT14 gene.
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